Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke

Neurobiology of Disease

Volumn 29, Issue 1, 2008, Pages 123-131

  Hurtado, O ^a   Pradillo, J M ^a   Fernandez Lopez D ^a   Morales, J R ^a   Sobrino, T ^b   Castillo, J ^b   Alborch, E ^c   Moro, M A ^a   Lizasoain, I ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Glutamate; Glutamate transporters; Ischemia

Indexed keywords

CITICOLINE; EXCITATORY AMINO ACID TRANSPORTER 2; FLOTILLIN 1; SPHINGOMYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN INFARCTION SIZE; CENTRIFUGATION; CONTROLLED STUDY; DRUG MECHANISM; LIPID RAFT; MEMBRANE STABILIZATION; MEMBRANE VESICLE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; STROKE;

ANIMALS; CELL FRACTIONATION; CYTIDINE DIPHOSPHATE CHOLINE; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID TRANSPORTER 2; GENE EXPRESSION REGULATION; GLUTAMIC ACID; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MEMBRANE MICRODOMAINS; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED F344; TIME FACTORS;

EID: 36549053140     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.08.004     Document Type: Article

References (64)

1. Adibhatla R.M., and Hatcher J.F. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J. Neurosci. Res. 70 (2002) 133-139
2. Adibhatla R.M., and Hatcher J.F. Cytidine 5′-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem. Res. 30 (2005) 15-23
3. Adibhatla R.M., Hatcher J.F., and Dempsey R.J. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke 32 (2001) 2376-2381
4. Adibhatla R.M., Hatcher J.F., and Dempsey R.J. Citicoline: neuroprotective mechanisms in cerebral ischemia. J. Neurochem. 80 (2002) 12-23
5. Alkan T., Kahveci N., Goren B., Korfali E., and Ozluk K. Ischemic brain injury caused by interrupted versus uninterrupted occlusion in hypotensive rats with subarachnoid hemorrhage: neuroprotective effects of citicoline. Arch. Physiol. Biochem. 109 (2001) 161-167
6. Alvarez X.A., Sampedro C., Lozano R., and Cacabelos R. Citicoline protects hippocampal neurons against apoptosis induced by brain beta-amyloid deposits plus cerebral hypoperfusion in rats. Methods Find. Exp. Clin. Pharmacol. 21 (1999) 535-540
7. Andersen M., Overgaard K., Meden P., Boysen G., and Choi S.C. Effects of citicoline with thrombolytic therapy in a rat embolic stroke model. Stroke 30 (1999) 1464-1471
8. Aronowski J., Strong R., and Grotta J.C. Citicoline for treatment of experimental focal ischemia: histologic and behavioral outcome. Neurol. Res. 18 (1996) 570-574
9. Besshoh S., Bawa D., Teves L., Wallace M.C., and Gurd J.W. Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J. Neurochem. 93 (2005) 186-194
10. Bickel P.E., Scherer P.E., Schnitzer J.E., Oh P., Lisanti M.P., and Lodish H.F. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem. 272 (1997) 13793-13802
11. Butchbach M.E., Tian G., Guo H., and Lin L.C. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. J. Biol. Chem. 279 (2004) 34388-34396
12. Castillo J., Dávalos A., Naveiro J., and Noya M. Neuroexcitatory amino acids and their relationship to infarct size and neurological deficit in ischemic stroke. Stroke 27 (1996) 1060-1065
13. Castillo J., Dávalos A., and Noya M. Progression of ischemic stroke and excitotoxic amino acids. Lancet 349 (1997) 79-83
14. Choi D.W., and Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13 (1990) 171-182
15. Dabir D.V., Robinson M.B., Swanson E., Zhang B., Trojanowski J.Q., Lee V.M., and Forman M.S. Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J. Neurosci. 26 (2006) 644-654
16. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
17. Daniels K.K., and Vickroy T.W. Simultaneous isolation of glial and neuronal fractions from rat brain homogenates: comparison of high-affinity l-glutamate transport properties. Neurochem. Res. 23 (1998) 103-113
18. Dávalos A., Castillo J., Alvarez-Sabín J., Secades J.J., Mercadal J., Lopez S., Cobo E., Warach S., Sherman D., Clark W.M., and Lozano R. Oral citicoline in acute ischemic stroke. An individual patient data pooling analysis of clinical trials. Stroke 33 (2002) 2850-2857
19. De Cristóbal J., Moro M.A., Dávalos A., Castillo J., Leza J.C., Camarero J., Colado M.I., Lorenzo P., and Lizasoain I. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischemia in rats. J. Neurochem. 79 (2001) 456-459
20. Dorman R.V., Dabrowiecki Z., and Horrocks L.A. Effects of CDPcholine and CDPethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia. J. Neurochem. 40 (1983) 276-279
21. Duan S., Anderson C.M., Stein B.A., and Swanson R.A. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J. Neurosci. 19 (1999) 10193-10200
22. Escartin C., Brouillet E., Gubellini P., Trioulier Y., Jacquard C., Smadja C., Knott G.W., Kerkerian-Le Goff L., Déglon N., Hantraye P., and Bonvento G. Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. J. Neurosci. 26 (2006) 5978-5989
23. Fivaz M., Abrami L., and Van der Goot F.G. Landing on lipid rafts. Trends Cell Biol. 9 (1999) 212-213
24. Gegelashvili G., Robinson M.B., Trotti D., and Rauen T. Regulation of glutamate transporters in health and disease. Prog. Brain Res. 132 (2001) 267-286
25. Grieb P., Gadamski R., Wojda R., and Janisz M. CDP-choline, but not cytidine, protects hippocampal CA1 neurones in the gerbil following transient forebrain ischemia. Folia Neuropathol. 39 (2001) 141-145
26. Hamann M., Rossi D.J., Marie H., and Attwell D. Knocking out the glial glutamate transporter GLT-1 reduces glutamate uptake but does not affect hippocampal glutamate dynamics in early simulated ischemia. Eur. J. Neurosci. 15 (2002) 308-314
27. Hooper N.M. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae (review). Mol. Membr. Biol. 16 (1999) 145-156
28. Hurtado O., De Cristóbal J., Sánchez V., Lizasoain I., Cárdenas A., Pereira M.P., Colado M.I., Leza J.C., Lorenzo P., and Moro M.A. Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke. FASEB J. 17 (2003) 2082-2084
29. Hurtado O., Moro M.A., Cárdenas A., Sánchez V., Fernández-Tomé P., Leza J.C., Lorenzo P., Secades J.J., Dávalos A., Castillo J., and Lizasoain I. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol. Dis. 18 (2005) 336-345
30. Kakihana M., Fukuda N., Suno M., and Nagaoka A. Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke 19 (1988) 217-222
31. Krupinski J., Ferrer I., Barrachina M., Secades J.J., Mercadal J., and Lozano R. CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat. Neuropharmacology 42 (2002) 846-854
32. Li S., Mallory M., Alford M., Tanaka S., and Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J. Neuropathol. Exp. Neurol. 56 (1997) 901-911
33. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., and Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20 (1998) 589-602
34. Lipton S.A., and Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330 (1994) 613-622
35. Lotocki G., Alonso O.F., Dietrich W.D., and Keane R.W. Tumor necrosis factor receptor 1 and its signalling intermediates are recruited to lipid rafts in the traumatized brain. J. Neurosci. 8 (2004) 11010-11016
36. Mackensen G.B., Patel M., Sheng H., Calvi C.L., Batinic-Haberle I., Day B.J., Liang L.P., Fridovich I., Crapo J.D., Pearlstein R.D., and Warner D.S. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. J. Neurosci. 21 (2001) 4582-4592
37. Mallolas J., Hurtado O., Castellanos M., Blanco M., Sobrino T., Serena J., Vivancos J., Castillo J., Lizasoain I., Moro M.A., and Dávalos A. A novel functional polymorphism in the EAAT2 gene is associated with higher glutamate concentrations and higher frequency of progressing stroke. J. Exp. Med. 203 (2006) 711-717
38. Maragakis N.J., and Rothstein J.D. Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis. 15 (2001) 461-473
39. Mukherjee S., Soe T.T., and Maxfield F.R. Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails. J. Cell Biol. 144 (1999) 1271-1284
40. Namura S., Maeno H., Takami S., Jiang X.F., Kamichi S., Wada K., and Nagata I. Inhibition of glial glutamate transporter GLT-1 augments brain edema after transient focal cerebral ischemia in mice. Neurosci. Lett. 324 (2002) 117-120
41. Onal M.Z., Li F., Tatlisumak T., Locke K.W., Sandage Jr. B.W., and Fisher M. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke 28 (1997) 1060-1065
42. Pawlak J., Brito V., Kuppers E., and Beyer C. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res. Mol. Brain Res. 138 (2005) 1-7
43. Pines G., Danbolt N.C., Bjoras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., and Kanner B.I. Cloning and expression of a rat brain l-glutamate transporter. Nature 360 (1992) 464-467
44. +-ATPase in adult rats. Clin. Biochem. 33 (2000) 351-357
45. Rao A.M., Hatcher J.F., and Dempsey R.J. Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection. J. Neurochem. 75 (2000) 2528-2535
46. Rao V.L.R., Dogan A., Todd K.G., Bowen K.K., Kim B.T., Rothstein J.D., and Dempsey R.J. Antisense knockdown of the glial glutamate transporter GLT-1, but not of the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J. Neurosci. 21 (2001) 1876-1883
47. Rigoulet M., Guerin B., Cohadon F., and Vandendreissche M. Unilateral brain injury in the rabbit: reversible and irreversible damage of the membranal ATPases. J. Neurochem. 32 (1979) 535-541
48. Robinson M.B. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem. Int. 33 (1999) 479-491
49. 3H]glutamate transport processes in rat brain. Brain Res. 544 (1991) 196-202
50. Romera C., Hurtado O., Mallolas J., Pereira M.P., Morales J.R., Romera A., Serena J., Vivancos J., Nombela F., Lorenzo P., Lizasoain I., and Moro M.A. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J. Cereb. Blood Flow Metab. 27 (2007) 1327-1338
51. Rothman S.M., and Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19 (1986) 105-111
52. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 73-84
53. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., and Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 (1996) 675-686
54. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., and Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433 (2005) 73-77
55. Schabitz W.R., Weber J., Takano K., Sandage B.W., Locke K.W., and Fisher M. The effects of prolonged treatment with citicoline in temporary experimental focal ischemia. J. Neurol. Sci. 138 (1996) 21-25
56. Schabitz W.R., Li F., Irie K., Sandage Jr. B.W., Locke K.W., and Fisher M. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke 30 (1999) 427-431
57. Seal R.P., and Amara S.G. Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 431-456
58. Shashidharan P., Huntley G.W., Meyer T., Morrison J.H., and Plaitakis A. Neuron-specific human glutamate transporter: molecular cloning, characterization and expression in human brain. Brain Res. 662 (1994) 245-250
59. Shuaib A., Yang Y., and Li Q. Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: neuroprotective effects when used alone or in combination with urokinase. Exp. Neurol. 161 (2000) 733-739
60. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
61. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev., Mol. Cell Biol. 1 (2000) 31-39
62. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., and Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276 (1997) 1699-1702
63. Zschocke J., Bayatti N., and Behl C. Caveolin and GLT-1 gene expression is reciprocally regulated in primary astrocytes: association of GLT-1 with non-caveolar lipid rafts. Glia 49 (2005) 275-287
64. Zschocke J., Bayatti N., Clement A.M., Witan H., Figiel M., Engele J., and Behl C. Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J. Biol. Chem. 280 (2005) 34924-34932